Biocept to host kol webinar today to discuss its proprietary cnside™ assay to detect and quantify cancer that metastasized to the central nervous system

San diego--(business wire)--biocept, inc. (nasdaq: bioc), a leading provider of molecular diagnostic assays, products and services, announces an hour-long webinar to be held today, october 14 at 1 p.m.
BIOC Ratings Summary
BIOC Quant Ranking